They also follow a recent partnership with Costco, which began offering low-dose Ozempic and Wegovy for $499 per month out of ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

Robbie Williams' concerns over weight-loss injections potentially harming his eyesight have sparked widespread worry. While ...

Semaglutide, an active ingredient in weight-loss drugs like Wegovy and Ozempic, surprisingly offers significant heart benefits unrelated to weight loss.

GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to ...

AbbVie and Genmab have received FDA approval for Epkinly as a treatment option for patients with relapsed or refractory follicular lymphoma. The decision adds a new targeted immunotherapy to the ...

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

JOANNA had struggled with her weight for years – but despite trying her hardest to shed the excess pounds, she’d quickly pile ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...

Shares of Vanda Pharmaceuticals VNDA rallied 21.6% on Tuesday after the company reported positive top-line results from a mid ...

For investors in Novo Nordisk (NYSE: NVO), 2025 has been a challenging year. After reaching a 52-week high of over $112, the ...

In today’s Pharma Pulse, learn how digital pharmacy safety gaps, Novo Nordisk’s introductory programs for Wegovy and Ozempic, and Scott Gottlieb’s new role at UnitedHealth are shaping patient access ...